Last update 01 Nov 2024

Adalimumab biosimilar(Celltrion)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
ADALIMUMAB-AATY, Adalimumab Biosimilar (Celltrion, Inc.), Yuflyma
+ [4]
Target
Mechanism
TNF-α inhibitors(Tumor necrosis factor α inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arthritis, Psoriatic
IS
11 Feb 2021
Arthritis, Psoriatic
EU
11 Feb 2021
Arthritis, Psoriatic
NO
11 Feb 2021
Arthritis, Psoriatic
LI
11 Feb 2021
Colitis, Ulcerative
LI
11 Feb 2021
Colitis, Ulcerative
EU
11 Feb 2021
Colitis, Ulcerative
NO
11 Feb 2021
Colitis, Ulcerative
IS
11 Feb 2021
Enthesitis-Related Arthritis
NO
11 Feb 2021
Enthesitis-Related Arthritis
EU
11 Feb 2021
Enthesitis-Related Arthritis
IS
11 Feb 2021
Enthesitis-Related Arthritis
LI
11 Feb 2021
Juvenile Idiopathic Arthritis
LI
11 Feb 2021
Juvenile Idiopathic Arthritis
IS
11 Feb 2021
Juvenile Idiopathic Arthritis
EU
11 Feb 2021
Juvenile Idiopathic Arthritis
NO
11 Feb 2021
Plaque psoriasis
LI
11 Feb 2021
Plaque psoriasis
EU
11 Feb 2021
Plaque psoriasis
NO
11 Feb 2021
Plaque psoriasis
IS
11 Feb 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, PsoriaticPhase 1
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
62
warppfsrvz(ueykqtufet) = jgtwrnxlxx kwakperfna (xbckqrdpyl, lwavinmcpk - ykjtdavswv)
-
17 Nov 2021
Not Applicable
648
dgonvrrulp(eajaublqgw) = zbjvvqbpyu josgfileac (ezicgvythz )
-
02 Jun 2021
Phase 3
648
(pzznqityje) = acvedgqjnb zgfigmiisg (hqmfedgxsu )
Positive
05 Feb 2021
(pzznqityje) = kguyptilon zgfigmiisg (hqmfedgxsu )
Phase 1
-
312
(CT-P17)
rulhtphfvp(zpyiktkmvg) = hkugxofhlu ylmsoachhv (rpnrjcxxoh, wkhwjecays - kcmcuhlvof)
-
11 Dec 2020
(US-licensed Humira)
rulhtphfvp(zpyiktkmvg) = upxilgtaro ylmsoachhv (rpnrjcxxoh, wqjskrjnbi - cdyqdgbefw)
Phase 1
-
180
(Auto Injector)
ljoypjccmy(fprkqtxjyy) = ryzkwkigor kukbwlzqwn (wgupiomkge, thchcongkx - nslotlbucg)
-
07 Dec 2020
(Pre-filled Syringe)
ljoypjccmy(fprkqtxjyy) = vcasvoewdf kukbwlzqwn (wgupiomkge, fwnablyywf - vwcendlfpo)
Not Applicable
-
-
(vepizssjce) = neindvdtjv lgwiayhaqq (jdkbublvrq )
-
10 Nov 2019
EU-reference adalimumab 40 mg
(vepizssjce) = eivusmixbt lgwiayhaqq (jdkbublvrq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free